Overview

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
To determine the safety of levocetirizine in children ages 6-11 months with symptoms of allergic rhinitis or chronic idiopathic urticaria.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma
Treatments:
Cetirizine
Levocetirizine